So-Young International Inc. (SY)

NASDAQ • Market Data in USD, Fundamentals in CNY

$282.00

-$3.98

-1.39%

Last Update: 18 Jul 2026, 12:52

$37.11bn

Market Cap

-979.51

P/E Ratio (TTM)

—

Forward Dividend Yield

$205.11-$380.58

52 Week Range

SY Stock Price Chart

Explore So-Young International Inc. interactive price chart. Choose custom timeframes to analyze SY price movements and trends.

SY Company Profile

Discover essential business fundamentals and corporate details for So-Young International Inc. (SY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

2 May 2019

Employees

1.80k

Website

https://www.soyoung.com

CEO

Xing Jin

Description

So-Young International Inc. manages a digital platform specializing in medical aesthetics and elective healthcare services, serving customers in the People's Republic of China and globally. This online ecosystem enables users to explore content, share personal experiences regarding medical aesthetic procedures, and book in-person treatments with various medical aesthetic service providers. The platform also offers resources for researching treatment trends, features ratings and reviews of treatment experiences, and publishes blogs under headings like "Beauty Diaries." Beyond cosmetic enhancements, So-Young facilitates reservations for a broader spectrum of healthcare needs, including dermatology, dentistry (with orthodontics), ophthalmology, comprehensive physical examinations, gynecology, human papillomavirus vaccinations, and postnatal support. The company also supplies Software-as-a-Service (SaaS) solutions and provides guidance and training programs to medical service providers. Its offerings extend to internet information and technology advisory, management consulting, and internet culture services. Furthermore, So-Young is involved in the sale of medical equipment, equipment manufacturing, sales, and agency services, as well as microfinance. As of December 31, 2021, its platform had established connections with approximately 8,400 medical aesthetic service providers and an additional 5,000 providers offering other consumption-focused healthcare services. Established in 2013, So-Young International Inc. maintains its corporate headquarters in Beijing, China.

SY Financial Timeline

Browse a chronological timeline of So-Young International Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 13 Aug 2026

EPS estimate is -$0.09, while revenue estimate is $70.40m.

Earnings released on 22 May 2026

EPS came in at -$0.07 surpassing the estimated -$0.10 by +33.25%, while revenue for the quarter reached $62.72m , beating expectations by +4.19%.

Earnings released on 25 Mar 2026

EPS came in at -$0.13 falling short of the estimated -$0.10 by -33.46%, while revenue for the quarter reached $65.86m , beating expectations by +5.51%.

Earnings released on 17 Nov 2025

EPS came in at -$0.09 falling short of the estimated -$0.05 by -92.97%, while revenue for the quarter reached $54.30m , beating expectations by +0.01%.

Earnings released on 15 Aug 2025

EPS came in at -$0.04 falling short of the estimated -$0.02 by -166.67%, while revenue for the quarter reached $52.85m , beating expectations by +4.56%.

Earnings released on 16 May 2025

EPS came in at -$0.04 surpassing the estimated -$0.05 by +15.47%, while revenue for the quarter reached $40.95m , beating expectations by +1.20%.

Dividend declared on 8 Apr 2025

A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 25 Apr 2025.

Earnings released on 28 Mar 2025

EPS came in at -$0.07 falling short of the estimated $0.01 by -682.85%, while revenue for the quarter reached $50.57m , missing expectations by -8.29%.

Earnings released on 20 Nov 2024

EPS came in at $0.03 surpassing the estimated $0.00 by +923.89%, while revenue for the quarter reached $52.97m , beating expectations by +2.12%.

Earnings released on 23 Aug 2024

EPS came in at $0.02 falling short of the estimated $0.03 by -29.15%, while revenue for the quarter reached $56.04m , beating expectations by +5.27%.

Earnings released on 28 May 2024

EPS came in at -$0.02 falling short of the estimated -$0.01 by -123.30%, while revenue for the quarter reached $44.06m , beating expectations by +4.83%.

Dividend declared on 11 Apr 2024

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 29 Apr 2024.

Earnings released on 20 Mar 2024

EPS came in at $0.06 surpassing the estimated $0.02 by +177.01%, while revenue for the quarter reached $55.01m , beating expectations by +6.33%.

Earnings released on 20 Nov 2023

EPS came in at $0.01 falling short of the estimated $0.02 by -49.97%, while revenue for the quarter reached $51.89m , missing expectations by -4.91%.

Earnings released on 21 Aug 2023

EPS came in at $0.02 falling short of the estimated $1.19 by -98.32%, while revenue for the quarter reached $56.81m , beating expectations by +5.39%.

Earnings released on 22 May 2023

EPS came in at -$0.01 surpassing the estimated -$0.17 by +94.12%, while revenue for the quarter reached $45.14m , beating expectations by +1.01%.

Earnings released on 21 Mar 2023

EPS came in at $0.05 surpassing the estimated $0.02 by +150.00%, while revenue for the quarter reached $47.12m , beating expectations by +2.80%.

Earnings released on 18 Nov 2022

EPS came in at $0.01 falling short of the estimated $1.27 by -99.21%, while revenue for the quarter reached $45.43m , beating expectations by +5.31%.

Earnings released on 16 Aug 2022

EPS came in at -$0.03 falling short of the estimated $1.15 by -102.61%, while revenue for the quarter reached $46.12m , beating expectations by +8.18%.

Earnings released on 23 May 2022

EPS came in at -$0.07 falling short of the estimated $1.43 by -104.90%, while revenue for the quarter reached $47.35m , beating expectations by +1.45%.

Earnings released on 25 Mar 2022

EPS came in at -$0.03 falling short of the estimated $0.04 by -186.77%, while revenue for the quarter reached $70.75m , beating expectations by +1.27%.